Marshall Wace North America’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-551,654
| Closed | -$28.3M | – | 1893 |
|
|
2021
Q1 | $28.3M | Buy |
551,654
+10,264
| +2% | +$526K | 0.12% | 200 |
|
|
2020
Q4 | $33.5M | Sell |
541,390
-385,292
| -42% | -$23.9M | 0.15% | 167 |
|
|
2020
Q3 | $50.8M | Sell |
926,682
-623,452
| -40% | -$34.2M | 0.33% | 72 |
|
|
2020
Q2 | $89.2M | Buy |
1,550,134
+390,057
| +34% | +$22.4M | 0.59% | 35 |
|
|
2020
Q1 | $46.6M | Buy |
1,160,077
+1,100,759
| +1,856% | +$44.2M | 0.35% | 78 |
|
|
2019
Q4 | $2.35M | Buy |
59,318
+36,850
| +164% | +$1.46M | 0.01% | 544 |
|
|
2019
Q3 | $152K | Buy |
+22,468
| New | +$152K | ﹤0.01% | 999 |
|
|
2019
Q2 | – | Sell |
-16,938
| Closed | -$235K | – | 1762 |
|
|
2019
Q1 | $235K | Buy |
+16,938
| New | +$235K | ﹤0.01% | 948 |
|